anti hypertensive [phsu]
Efficacy [qlco]
olmesartan [orch, phsu]
Comparison [acty]
Angiotensin II Receptor Antagonists [phsu]
Hypertension [dsyn]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
effective [qlco]
Elevated blood pressure [fndg]
Risk Reduction [inbe]
Assumed [inpr]
Mechanism [ftcn]
Blood Pressure [orgf]
lowered [spco]
Little NOS [cgab, dsyn]
IMPACT [gngm]
Benefit [qnco]
Obtained [ftcn]
Suggest [idcn]
Agent [chvf]
arrested [dsyn]
Renin-angiotensin system [bdsy]
Heart [bpoc]
outcomes prevention [fndg]
Evaluation [ftcn]
Trial [resa]
Suggest [idcn]
Angiotensin-Converting Enzyme Inhibitors [phsu]
IMPACT [gngm]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
Antihypertensive [phsu]
effects [qlco]
Alone [qnco]
Angiotensin Receptor Blockers [phsu]
Class [inpr]
Anti-Hypertensive Drugs [phsu]
arrested [dsyn]
Renin-angiotensin system [bdsy]
tested [inpr]
Trial [resa]
Suggest [idcn]
controlling [ftcn]
Target [ftcn]
Organ [bpoc]
Damage [inpo]
Hypertension [dsyn]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Agent [chvf]
Side Effect [patf]
Profile [lbpr]
placebo [topp]
Based [ftcn]
Efficacy [qlco]
controlling hypertension [fndg]
Wide [spco]
Health Benefits [qnco]
Minimal [qlco]
side effects [ftcn]
Angiotensin [aapp, bacs, phsu]
receptor [aapp, rcpt]
considered [idcn]
Line [spco]
Agent [chvf]
treatment [ftcn]
Hypertension [dsyn]
Patients [podg]
cardiovascular risk factor [dsyn]
Preliminary [tmco]
Suggest [idcn]
olmesartan [orch, phsu]
receptor [aapp, rcpt]
Currently [tmco]
Evaluated [ftcn]
Approval [qlco]
Antihypertensive [phsu]
Efficacy [qlco]
Superior [spco]
Class [inpr]
